DE122008000004I1 - Formulierung zur peptidfreisetzung - Google Patents

Formulierung zur peptidfreisetzung

Info

Publication number
DE122008000004I1
DE122008000004I1 DE122008000004C DE122008000004C DE122008000004I1 DE 122008000004 I1 DE122008000004 I1 DE 122008000004I1 DE 122008000004 C DE122008000004 C DE 122008000004C DE 122008000004 C DE122008000004 C DE 122008000004C DE 122008000004 I1 DE122008000004 I1 DE 122008000004I1
Authority
DE
Germany
Prior art keywords
formulation
relief
peptide
deslorelin
mug
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE122008000004C
Other languages
English (en)
Other versions
DE122008000004I2 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Teva Pharmaceuticals Australia Pty Ltd
Original Assignee
Peptech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peptech Ltd filed Critical Peptech Ltd
Publication of DE122008000004I1 publication Critical patent/DE122008000004I1/de
Publication of DE122008000004I2 publication Critical patent/DE122008000004I2/de
Active legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/09Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Steroid Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE122008000004C 1995-06-20 1996-06-20 Formulierung zur peptidfreisetzung Active DE122008000004I2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPN3667A AUPN366795A0 (en) 1995-06-20 1995-06-20 Formulation for preventing reproductive function
PCT/AU1996/000370 WO1997000693A1 (en) 1995-06-20 1996-06-20 Novel formulation for peptide release

Publications (2)

Publication Number Publication Date
DE122008000004I1 true DE122008000004I1 (de) 2008-04-17
DE122008000004I2 DE122008000004I2 (de) 2009-08-06

Family

ID=3788008

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69623652T Expired - Lifetime DE69623652T2 (de) 1995-06-20 1996-06-20 Formulierung zur peptidfreisetzung
DE122008000004C Active DE122008000004I2 (de) 1995-06-20 1996-06-20 Formulierung zur peptidfreisetzung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69623652T Expired - Lifetime DE69623652T2 (de) 1995-06-20 1996-06-20 Formulierung zur peptidfreisetzung

Country Status (17)

Country Link
US (2) US5925619A (de)
EP (1) EP0871467B1 (de)
JP (1) JP4016133B2 (de)
CN (1) CN1145496C (de)
AT (1) ATE223726T1 (de)
AU (2) AUPN366795A0 (de)
CA (1) CA2225796C (de)
DE (2) DE69623652T2 (de)
DK (1) DK0871467T3 (de)
ES (1) ES2182983T3 (de)
FR (1) FR08C0001I2 (de)
HK (1) HK1014874A1 (de)
NL (1) NL300330I2 (de)
NZ (1) NZ309697A (de)
PT (1) PT871467E (de)
SI (1) SI0871467T1 (de)
WO (1) WO1997000693A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function
EP1007080B1 (de) 1996-08-30 2007-04-18 Peptech Limited Formulierung zur verzögerten Freisetzung von Peptidagonisten und -analoga des GnRH
BR9912275A (pt) * 1998-07-20 2001-04-17 Peptech Ltd Formulação de bioimplante
US8052982B2 (en) * 1998-07-20 2011-11-08 Peptech Animal Health Pty Limited Bioimplant formulation comprising lecithin and stearin
US6211221B1 (en) * 1999-04-05 2001-04-03 Johnny W. Peterson Dietary supplement containing histidine for alleviating dysmenorrhea, endometriosis, and pre-term labor
AU2001295359A1 (en) * 2000-10-30 2002-05-15 University Of Zurich GnRH analogues for treatment of urinary incontinence
GB0221539D0 (en) * 2002-09-17 2002-10-23 Medical Res Council Methods of treatment
WO2005067889A1 (en) * 2003-12-30 2005-07-28 Durect Corporation Polymeric implants, preferably containing a mixture of peg and plg, for controlled release of active agents, preferably a gnrh
US20080254086A1 (en) * 2004-12-23 2008-10-16 Brown James E Controlled Release Compositions
JP2010539010A (ja) * 2007-09-11 2010-12-16 モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト 治療剤としてのデスロレリンおよびマストパランの使用
DE102008015104A1 (de) 2008-03-19 2009-09-24 Basf Coatings Ag Beschichtungszusammensetzung, Verfahren zu ihrer Herstellung, ihre Verwendung und mit ihr beschichtete Substrate

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS563846B2 (de) * 1972-10-12 1981-01-27
US4218439A (en) * 1977-07-14 1980-08-19 The Salk Institute For Biological Studies Peptide which inhibits gonadal function
US4256737A (en) * 1979-06-11 1981-03-17 Syntex (U.S.A.) Inc. Long acting depot injectable formulations for LH-RH analogues
CA1257199A (en) * 1986-05-20 1989-07-11 Paul Y. Wang Preparation containing bioactive macromolecular substance for multi-months release in vivo
DE3777721D1 (de) * 1986-08-11 1992-04-30 American Cyanamid Co Zusammensetzungen zur parenteralen verabreichung und deren verwendung.
US4897268A (en) * 1987-08-03 1990-01-30 Southern Research Institute Drug delivery system and method of making the same
US5538739A (en) * 1989-07-07 1996-07-23 Sandoz Ltd. Sustained release formulations of water soluble peptides
US5211952A (en) * 1991-04-12 1993-05-18 University Of Southern California Contraceptive methods and formulations for use therein
US5470582A (en) * 1992-02-07 1995-11-28 Syntex (U.S.A.) Inc. Controlled delivery of pharmaceuticals from preformed porous polymeric microparticles
AUPN366795A0 (en) * 1995-06-20 1995-07-13 Peptide Technology Limited Formulation for preventing reproductive function

Also Published As

Publication number Publication date
EP0871467A4 (de) 2000-07-05
CN1145496C (zh) 2004-04-14
DE122008000004I2 (de) 2009-08-06
US6211152B1 (en) 2001-04-03
US5925619A (en) 1999-07-20
HK1014874A1 (en) 1999-10-08
AUPN366795A0 (en) 1995-07-13
JP2001521482A (ja) 2001-11-06
EP0871467A1 (de) 1998-10-21
ES2182983T3 (es) 2003-03-16
CA2225796A1 (en) 1997-01-09
SI0871467T1 (en) 2003-08-31
FR08C0001I1 (de) 2008-03-21
NZ309697A (en) 1999-11-29
EP0871467B1 (de) 2002-09-11
FR08C0001I2 (de) 2009-11-20
JP4016133B2 (ja) 2007-12-05
DE69623652D1 (de) 2002-10-17
AU701837B2 (en) 1999-02-04
AU5992796A (en) 1997-01-22
PT871467E (pt) 2002-12-31
NL300330I1 (nl) 2008-03-03
DK0871467T3 (da) 2002-12-23
WO1997000693A1 (en) 1997-01-09
DE69623652T2 (de) 2003-05-28
CN1188414A (zh) 1998-07-22
NL300330I2 (nl) 2008-04-01
ATE223726T1 (de) 2002-09-15
CA2225796C (en) 2011-09-20

Similar Documents

Publication Publication Date Title
FR08C0001I2 (de)
AU4718496A (en) Use of aerogels in agriculture
FI963696A (fi) Geeli ihosairauksien hoitoon ja ihon desinfiointiin
ES2184895T3 (es) Sistema no polimerico de administracion con liberacion retardada.
MY113488A (en) Compounds with growth hormone releasing properties
AU6414994A (en) Composition and method for reducing toxicity of biologically-active factors
DE69532921D1 (de) Angesäuertes nitrit zur verwendung als antimikrobielles mittel
EP1178988A4 (de) Verbindungen und therapeutische methoden
MY138883A (en) Use of asiatic acid for treatment of cencer
BR9607541A (pt) Tratamento de doenças que tem por causa o fator de crescimento da citoquina
PL318130A1 (en) Terpenod derivatives (of sarcodictyine)as antineoplastic agents
AU5643299A (en) Humic acid and its use in the treatment of various conditions
WO1994020115A3 (en) Hyaluronic acid used as a cancer treatment
OA09771A (en) Asphodelus composition for increasing white blood cell count.
UA30723A (uk) Спосіб лікування аутоімунних захворювань
UA7163A (uk) Спосіб відновлення ушкоджених тканин людини чи тварини
BG51699A1 (en) Stimulating fertility agent
UA10825A (uk) Протимікробhий засіб
SU1727241A1 (ru) Способ стимулирования воспроизводительной функции животных